亚洲AV成人片色在线观看高潮_亚洲精品成a人在线观看夫_日本久久久久久久久精品_亚洲精品无码成人在线观看

Ⅰ類主要組織相容性復(fù)合體G(MHCG)多克隆抗體

Polyclonal Antibody to Major Histocompatibility Complex Class I G (MHCG)

HLA-G; MHC-G; HLAG; Leukocyte Antigen G; b2 microglobulin; HLA class I histocompatibility antigen, alpha chain G

  • Ⅰ類主要組織相容性復(fù)合體G(MHCG)多克隆抗體 產(chǎn)品包裝(模擬)
  • Ⅰ類主要組織相容性復(fù)合體G(MHCG)多克隆抗體 產(chǎn)品包裝(模擬)
  • PAB856Hu02.jpg Western Blot; Sample: Hela cell lysate Primary Ab: 0.04μg/ml Rabbit Anti-Human MHCG Antibody Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對MHCG的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別MHCG。

用法

Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號 適用物種:Homo sapiens (Human,人) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPB856Hu01 Ⅰ類主要組織相容性復(fù)合體G(MHCG)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB856Hu02 Ⅰ類主要組織相容性復(fù)合體G(MHCG)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB856Hu02 Ⅰ類主要組織相容性復(fù)合體G(MHCG)多克隆抗體 WB; IHC; ICC; IP.
PAB856Hu01 Ⅰ類主要組織相容性復(fù)合體G(MHCG)多克隆抗體 WB; IHC; ICC; IP.
LAB856Hu71 Ⅰ類主要組織相容性復(fù)合體G(MHCG)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
MAB856Hu22 Ⅰ類主要組織相容性復(fù)合體G(MHCG)單克隆抗體 WB; IHC; ICC; IP.
SEB856Hu Ⅰ類主要組織相容性復(fù)合體G(MHCG)檢測試劑盒(酶聯(lián)免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB856Hu Ⅰ類主要組織相容性復(fù)合體G(MHCG)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻

雜志 參考文獻
Lupus Lack of association between HLA-G 14-bp polymorphism and systemic lupus erythematosus in a Han Chinese population [SAGE: source]
Exp Clin Transplant Major Vascular Complications in Living-Donor Liver Transplant Recipients: Single Center Team Experience [PubMed: 25894130]
International Immunopharmacology Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients. [pubmed:28129605]
Scientific Reports Serum sHLA-G: Significant diagnostic biomarker with respect to therapy and immunosuppressive mediators in Head and Neck Squamous Cell Carcinoma [Pubmed: 32123232]
留言咨詢